Resistant Hypertension

  • R. C. Tarazi
Chapter

Abstract

The problem of resistant hypertension is peculiar in that its magnitude depends in great part on its definition. If the term is taken to mean severe hypertension resistant to modern antihypertensive therapy, the problem is restricted to relatively small numbers of patients. However, if the term refers to patients whose blood pressure is not normalized by treatment, then resistant hypertension is a common and probably growing problem. The paradox of a seeming increase in resistant hypertension despite the greater number of effective drugs can be ex-plained by many factors, including the increase in the total number of patients undergoing treatment and the greater sensitivity to the need for optimal blood pressure control. Given the importance of hypertension as a risk factor for heart failure, myocardial infarction, and strokes, the broader definition of “resistance to treatment” seems the more appropriate.

Keywords

Blood Pressure Control Blood Pressure Response Resistant Hypertension Renovascular Hypertension Poor Blood Pressure Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bauer GE, Baker J, Hunyor SN, Marshall P (1978) Side-effects of antihypertensive treatment: A placebo-controlled study. Clin Sci Mol Med 44: 341s–344sGoogle Scholar
  2. 2.
    Dustan HP, Tarazi RC, Bravo EL (1976) False tolerance to antihypertensive drugs. In: Sambhi MP (ed) Systemic Effects of Antihypertensive Agents. Symposia Specialists Medical Books, New York, pp 51–68Google Scholar
  3. 3.
    Finnerty FA Jr, Davidov M, Kakaviators N (1967) Hypertensive vascular disease. The long term effect of rapid repeated reduction of arterial pressure with diazoxide. Am J Cardiol 19: 337–384Google Scholar
  4. 4.
    Gifford RW Jr, Tarazi RC (1978) Resistant hyper-tension: Diagnosis and management. Ann Intern Med 88: 661–665PubMedGoogle Scholar
  5. 5.
    Laragh JH (1978) The renin system in high blood pressure, from disbelief to reality: Converting enzyme blockade for analysis and treatment. Prog Cardiovasc Dis 21: 159–166PubMedCrossRefGoogle Scholar
  6. 6.
    Page IH (1949) Pathogenesis of arterial hyperten-sion. JAMA 140: 451 458Google Scholar
  7. 7.
    Page IH (1976) Commentary: Egregious errors in the management of hypertension. JAMA 236: 2621–2622PubMedCrossRefGoogle Scholar
  8. 8.
    Pettinger WA, Mitchell HC (1973) Minoxidil—an alternative to nephrectomy for refractory hypertension. N Engl J Med 289: 167–171PubMedCrossRefGoogle Scholar
  9. 9.
    Tarazi RC (1977) Hypertension. In: Conn HF (ed) Current Therapy. Saunders, Philadelphia, pp 205–221Google Scholar
  10. 10.
    Tarazi RC, Bravo EL, Fouad FM, Omvik P, Cody RJ Jr (1980) Hemodynamic and volume changes associated with captopril. Hypertension 2 (4): 576–585PubMedGoogle Scholar
  11. 11.
    Van Zwieten PA (1975) Interaction between centrally acting hypotensive drugs and tricyclic anti-depressants. Arch Int Pharmacodyn Ther 214: 12–30PubMedGoogle Scholar
  12. 12.
    Zacharias FJ, Cowen KJ, Presstt J, Vickers BG, Vickers J, Wall BG (1972) Propranolol in hypertension: A study of long-term therapy, 1964–1970. Am Heart J 83: 755PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1982

Authors and Affiliations

  • R. C. Tarazi

There are no affiliations available

Personalised recommendations